Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...

Organoids have now evolved beyond simple experimental models to become next-generation biological platforms that precisely replicate human organ ...

New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

Next-gen nuclear is one of our 10 Breakthrough Technologies this year. If you want to learn more about why it made the list, ...

Using CLASSIC, Rice researchers realized that circuits are variable, having multiple pathways to elicit the same outcome.

Image, trained entirely on Huawei chips, as Beijing moves to block Nvidia H200 imports in a push for AI self-reliance.

The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.